Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
International scientists are challenging their colleagues to make Artificial Intelligence (AI) research more transparent and reproducible to accelerate the impact of their findings for cancer patients.
In an article published in Nature on Oct. 14, scientists at Princess Margaret Cancer Centre, University of Toronto, Stanford University, Johns Hopkins University, Harvard University School of Public Health, Massachusetts Institute of Technology, and others, challenge scientific journals to hold computational researchers to higher standards of transparency, and call for their colleagues to share their code, models and computational environments in publications.
"Scientific progress depends on the ability of researchers to scrutinize the results of a study and reproduce the main finding to learn from," says Dr. Benjamin Haibe-Kains, Senior Scientist at Princess Margaret Cancer Centre and first author of the article.
"But in computational research, it's not yet a widespread criterion for the details of an AI study to be fully accessible. This is detrimental to our progress."
The authors voiced their concern about the lack of transparency and reproducibility in AI research after a Google Health study by McKinney et al., published in a prominent scientific journal in January 2020, claimed an AI system could outperform human radiologists in both robustness and speed for breast cancer screening. The study made waves in the scientific community and created a buzz with the public, with headlines appearing in
A closer examination raised some concerns: the study lacked a sufficient description of the methods used, including their code and models. The lack of transparency prohibited researchers from learning exactly how the model works and how they could apply it to their own institutions.
"On paper and in theory, the McKinney et al. study is beautiful," says Dr. Haibe-Kains, "But if we can't learn from it then it has little to no scientific value."
Journals are vulnerable to the 'hype' of AI and may lower standards
According to Dr. Haibe-Kains, who is jointly appointed as Associate Professor in Medical Biophysics at the University of Toronto and affiliate at the Vector Institute for Artificial Intelligence, this is just one example of a problematic pattern in computational research.
"Researchers are more incentivized to publish their finding rather than spend time and resources ensuring their study can be replicated," explains Dr. Haibe-Kains. "Journals are vulnerable to the 'hype' of AI and may lower the standards for accepting papers that don't include all the materials required to make the study reproducible – often in contradiction to their own guidelines."
This can actually slow down the translation of AI models into clinical settings. Researchers are not able to learn how the model works and replicate it in a thoughtful way. In some cases, it could lead to unwarranted clinical trials, because a model that works on one group of patients or in one institution, may not be appropriate for another.
In the article titled
Transparency and reproducibility in artificial intelligence, the authors offer numerous frameworks and platforms that allow safe and effective sharing to uphold the three pillars of open science to make AI research more transparent and reproducible: sharing data, sharing computer code and sharing predictive models.
"We have high hopes for the utility of AI for our cancer patients," says Dr. Haibe-Kains. "Sharing and building upon our discoveries – that's real scientific impact."
Michael M. Hoffman received a GPU Grant from Nvidia. Benjamin Haibe-Kains is a scientific advisor for Altis Labs. Chris McIntosh holds an equity position in Bridge7Oncology and receives royalties from RaySearch Laboratories.